A. Deichmann

发表

Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β‐thalassemia patient

C. Eaves, A. Cheung, S. Fucharoen, 2013, Stem Cells.

Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy.

C. von Kalle, A. Fischer, Claudia Cattoglio, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

HIV- 1 lentivirus tethering to the genome is associated with transcription factor binding sites found in genes that favour virus survival

Y. Takeuchi, R. Fronza, S. Jobling, 2022, Gene Therapy.

Real-Time Definition of Non-Randomness in the Distribution of Genomic Events

C. von Kalle, A. Fischer, M. Cavazzana‐Calvo, 2007, PloS one.

Pioneer Vector Integration and Tumorigenesis

Manfred Schmidt, C. Kalle, A. Deichmann, 2014 .

Cell Cycle Status of CD34+ Hemopoietic Stem Cells Determines Lentiviral Integration in Actively Transcribed and Development-related Genes.

C. von Kalle, I. Kasampalidis, N. Anagnou, 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy.

Bruce Aronow, Christof von Kalle, Jean Weissenbach, 2007, The Journal of clinical investigation.

Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo.

Christine Kinnon, Christof von Kalle, Dick de Ridder, 2007, The Journal of clinical investigation.

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1

Yang Du, Manuel Grez, Hanno Glimm, 2006, Nature Medicine.

Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-Thalassemia and Sickle Cell Disease

C. von Kalle, G. Veres, B. Ryu, 2014, Current gene therapy.

Vector integration and tumorigenesis.

C. von Kalle, Manfred Schmidt, A. Deichmann, 2014, Human gene therapy.

Bioinformatic clonality analysis of next-generation sequencing-derived viral vector integration sites.

Christof von Kalle, Richard Gabriel, Hanno Glimm, 2012, Human gene therapy methods.

Analyzing the Number of Common Integration Sites of Viral Vectors – New Methods and Computer Programs

Christof von Kalle, Richard Gabriel, Hanno Glimm, 2011, PloS one.

Comprehensive genomic access to vector integration in clinical gene therapy

Luca Biasco, Alessandro Aiuti, Richard Gabriel, 2009, Nature Medicine.

Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis.

C. von Kalle, B. Fehse, Johann Meyer, 2005, Blood.

Biosafety considerations using gamma-retroviral vectors in gene therapy.

Manfred Schmidt, A. Deichmann, 2014, Current gene therapy.

Mutations in ROGDI Cause Kohlschütter-Tönz Syndrome.

Zlatko Trajanoski, Stephan Pabinger, Christof von Kalle, 2012, American journal of human genetics.

The LAM-PCR Method to Sequence LV Integration Sites.

Wei Wang, Richard Gabriel, Manfred Schmidt, 2016, Methods in molecular biology.

Modeling and Increasing the Genome Accessibility of Viral Integration Sites

Alessandro Aiuti, Steven J. Howe, Robin R. Ali, 2009 .